AbbVie

Enroll Now

Type of Study:

Blinded placebo controlled of topical Testosterone replacement therapy

Title of Study:

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events and Efficacy Measures in Hypogonadal Men

Short Title:

Traverse

Study Length: 14 months

Target Age/Sex: 45 - 80, Male

Benefits:

Participants will receive at no cost: study medication and study related supplies, study related lab work and study related exams.

Link: ClinicalTrials.gov

Live better, healthier, smarter

Schedule an Appointment